Overview
This study evaluates the amount of nicotine, cannabis, and toxicants linked to the use of nicotine e-cigarette and/or cannabis products in the blood and urine of young adult users as well as the cannabis and nicotine use behaviors of consumers.
Description
PRIMARY OBJECTIVE:
I. To evaluate differences in self-reported nicotine and cannabis use behaviors and biomarkers of exposure to toxicants and carcinogens by product use status, to generate effect sizes required to calculate sample sizes needed for a larger study.
Eligibility
Inclusion Criteria:
- Young adult (18-25 years old).
- Ability to read and write in English.
- Participants must fall into one of the following groups (based on self-report):
- Predominant e-cigarette consumer: defined as using nicotine-containing e-cigarettes daily for the past six months but not having used other nicotine containing products more than weekly or cannabis products for the past month.
- Predominant cannabis consumer: defined as using cannabis at least 3x/week for the past six months in any form, including smoking, vaping, and oral use, with no more than weekly use of any nicotine or tobacco products.
- E-cigarette-cannabis co-consumers: defined as daily use of nicotine e-cigarettes and use of cannabis at least 3x/week, including smoking, vaping, and oral use, for at least the past six months, with no use of other nicotine containing products more than weekly.
- No self-reported diagnosis of kidney disease (current, or within the past year prior to the study visit).
- Participants must understand the voluntary nature of this study and sign a written informed consent form before proceeding with study activities.
Exclusion Criteria:
- Individuals under the age of 18 or over the age of 25.
- Currently pregnant or breastfeeding (female participants).
- Unwilling or unable to follow protocol requirements